Acyclovir therapy for varicella in otherwise healthy children and adolescents
β Scribed by Dr. S Feldman
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 434 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
Acyclovir has been approved in the United States and elsewhere as antiviral therapy for otherwise healthy children and adolescents with varicella. This development arose from multicentre placebo-controlled trials of acyclovir in normal patients, 2-18 years of age, which showed that the drug accelerated cutaneous healing, and reduced fever and related constitutional symptoms without harmful side effects. Acyclovir did not, however, decrease transmission of chickenpox within the household, nor was there any demonstrable effect of antiviral therapy on varicelia complications. In this article, the background and rationale for the multicentre studies of acyclovir in normal paediatric patients with chickenpox is reviewed. The evidence for and against its routine administration within 24 hours of the eruption of skin rash is also discussed.
π SIMILAR VOLUMES
## Abstract ## Background Childhood and adolescent anxiety disorders are relatively common, occurring in between 5β18% of all children and adolescents. They are associated with significant morbidity and impairment in social and academic functioning, and when persistent, there is a risk of depressi
## Abstract These are the characteristics and key findings for a Cochrane review published in this issue of EBCH, first published as James A, Soler A, Weatherall R. Cognitive behavioural therapy for anxiety disorders in children and adolescents. __Cochrane Database of Systematic Reviews__ 2005, Iss